2.4 mg semaglutide to tirzepatide Switching from dosage chart Switching between weight-loss medications -

59: Conservative management approaches should be pursued before attempting surgical re-intervention as patients with dumping syndrome might experience symptomatic improvement over time Statement endorsed

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related conditions

This piece walks through the physiology, the best human clinical trials, safety differences, cost and convenience tradeoffs, and how a rigorously tested oral supplement fits between a bag of psyllium and prescription injectables

Knowing Your GLP-1 Medication's Storage Rules Here's where people often get caught out: not all GLP-1 medications have the same storage requirements, and those differences really matter when you're packing for a trip

Ready to glow like never before

In a patient with co-occurring major depressive disorder and alcohol use disorder, suppressing that pathway might attenuate craving